Monday, December 1, 2008 - 4:31PM EST

Review Articles

21. Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML.

Author
Craddock CF;
Institution
Centre for Clinical Haematology, University Hospital Birmingham NHS Trust, Birmingham, UK. charles.craddock@uhb.nhs.uk
Journal
Bone Marrow Transplant. 2008 Mar;41(5):415-23. Epub 2008 Jan 21.
Abstract URL
Click here to view abstract

22. Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia.

Author
Sierra J; Martino R; Sanchez B; Pinana JL; Valcarcel D; Brunet S;
Institution
Clinical Hematology Division and Hematopoietic Transplant Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain. jsierra@santpau.es
Journal
Bone Marrow Transplant. 2008 Mar;41(5):425-37. Epub 2008 Jan 21.
Abstract URL
Click here to view abstract

23. Umbilical cord blood transplantation in adult myeloid leukemia.

Author
Tse WW; Zang SL; Bunting KD; Laughlin MJ;
Institution
Division of Hematology/Oncology, Department of Medicine, Case Western Reserve University, Case Comprehensive Cancer Center, Abraham J. and Phyllis Katz Cord Blood Foundation, Center for Stem Cell and Regenerative Medicine, Cleveland, OH 44106-7284, USA.
Journal
Bone Marrow Transplant. 2008 Mar;41(5):465-72. Epub 2008 Feb 4.
Abstract URL
Click here to view abstract

24. Molecularly targeted therapies in myelodysplastic syndromes and acute myeloid leukemias.

Author
Morgan MA; Reuter CW;
Institution
Department of Hematology, Hemostasis and Oncology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. christophreuter@yahoo.com
Journal
Ann Hematol. 2006 Mar;85(3):139-63. Epub 2006 Jan 4.
Abstract URL
Click here to view abstract

25. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review.

Author
Oliansky DM; Rizzo JD; Aplan PD; Arceci RJ; Leone L; Ravindranath Y; Sanders JE; Smith FO 3rd; Wilmot F; McCarthy PL Jr; Hahn T;
Institution
Roswell Park Cancer Institute, Buffalo, New York 14263, USA.
Journal
Biol Blood Marrow Transplant. 2007 Jan;13(1):1-25.
Abstract URL
Click here to view abstract

26. Progress and strategies for patients with relapsed and refractory acute myeloid leukemia.

Author
Litzow MR;
Institution
Division of Hematology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA. Litzow.mark@mayo.edu
Journal
Curr Opin Hematol. 2007 Mar;14(2):130-7.
Abstract URL
Click here to view abstract

27. Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remission.

Author
Baron F; Storb R;
Institution
University of Liege, Liege, Belgium.
Journal
Curr Opin Hematol. 2007 Mar;14(2):145-51.
Abstract URL
Click here to view abstract

28. Alternative donor transplantation in acute myeloid leukemia: which source and when?

Author
Zuckerman T; Rowe JM;
Institution
Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel. t_zuckerman@rambam.health.gov.il
Journal
Curr Opin Hematol. 2007 Mar;14(2):152-61.
Abstract URL
Click here to view abstract

29. Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens.

Author
Greiner J; Dohner H; Schmitt M;
Institution
Tumor Immunology Group, Dept. of Internal Medicine III, Robert-Koch-Str. 8 University of Ulm, 89081 Ulm, Germany.
Journal
Haematologica. 2006 Dec;91(12):1653-61.
Abstract URL
Click here to view abstract

30. High-dose cytosine arabinoside in the treatment of acute myeloid leukemia: Review of three randomized trials.

Author
Kern W; Estey EH;
Institution
MLL Munich Leukemia Laboratory, Munich, Germany. wolfgang.kern@mll-online.com
Journal
Cancer. 2006 Jul 1;107(1):116-24.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5